| human | Q5 |
| P6178 | Dimensions author ID | 011306073213.98 |
| P496 | ORCID iD | 0000-0002-3809-2911 |
| P3368 | Prabook ID | 3398327 |
| P3829 | Publons author ID | 2667341 |
| P1053 | ResearcherID | C-1625-2013 |
| P1153 | Scopus author ID | 35481156500 |
| P166 | award received | Medal of the Order of Australia | Q9682417 |
| P27 | country of citizenship | Australia | Q408 |
| P69 | educated at | Vaucluse High School | Q7917247 |
| University of Sydney | Q487556 | ||
| P108 | employer | Heart Research Institute | Q17006364 |
| P734 | family name | Freedman | Q56035670 |
| Freedman | Q56035670 | ||
| Freedman | Q56035670 | ||
| P735 | given name | Ben | Q816407 |
| Ben | Q816407 | ||
| P106 | occupation | cardiologist | Q3264451 |
| P21 | sex or gender | male | Q6581097 |
| Q31125892 | "Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation |
| Q48714162 | AF-SCREEN international collaboration |
| Q91751159 | AF-SMART eHealth system for atrial fibrillation screening: how can it fit into clinical practice? |
| Q51132669 | Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. |
| Q90519491 | Age-and-sex stratified prevalence of atrial fibrillation in rural Western India: Results of SMART-India, a population-based screening study |
| Q91137747 | Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report |
| Q34793416 | Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. |
| Q58582424 | Atrial Fibrillation Screen, Management And Guideline Recommended Therapy (AF SMART II) in the rural primary care setting: an implementation study protocol |
| Q98513363 | Atrial Fibrillation in Indigenous Australians: A Multisite Screening Study Using a Single-Lead ECG Device in Aboriginal Primary Health Settings |
| Q58645594 | Atrial fibrillation |
| Q33444442 | Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation |
| Q90282005 | Atrial fibrillation: is there enough evidence to recommend opportunistic or systematic screening? |
| Q57188551 | Atrial fibrillation: is there enough evidence to recommend opportunistic or systematic screening? |
| Q91538600 | Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study |
| Q91892066 | Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis |
| Q58645702 | Beta-Blocker Dose Up-Titration or Addition of Ivabradine in Stable Angina: More is Not Necessarily Better |
| Q48183392 | Burden of Atrial Fibrillation in Māori and Pacific People in New Zealand: A Cohort Study |
| Q42489262 | C-reactive protein contributes to the hypercoagulable state in coronary artery disease. |
| Q58645599 | Can screening for atrial fibrillation be implemented at scale? |
| Q46737709 | Cardiac troponin-T and the prediction of acute and long-term mortality after acute pulmonary embolism |
| Q58645691 | Changing the lexicon of ‘Cardiac Rehabilitation’: a progressive step |
| Q48066338 | Choice of Health Options In prevention of Cardiovascular Events for people with Atrial Fibrillation (CHOICE-AF): A pilot study |
| Q47628388 | Choice of Health Options in Prevention of Cardiovascular Events (CHOICE) Replication Study |
| Q46100884 | Choice of secondary prevention improves risk factors after acute coronary syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial |
| Q38540068 | Clinical Exercise Stress Testing in Adults (2014). |
| Q98498632 | Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study |
| Q58645867 | Comparison of carvedilol and atenolol for angina pectoris |
| Q52603884 | Contact-Free Screening of Atrial Fibrillation by a Smartphone Using Facial Pulsatile Photoplethysmographic Signals. |
| Q58645910 | Coronary Artery Spasm* |
| Q58645914 | Coronary Artery Spasm: Use of Ergonovine in Diagnosis * |
| Q97553508 | Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): A prospective multicenter study |
| Q33252927 | Development and testing of innovative patient resources for the management of coronary heart disease (CHD): a descriptive study |
| Q58645785 | Differences in management and outcome of ischemic and non-ischemic cardiomyopathy |
| Q58645884 | Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris |
| Q54355730 | Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris. |
| Q44973053 | Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial |
| Q36266901 | Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina |
| Q58645833 | Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease |
| Q90280174 | Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals |
| Q58645856 | Evaluation of a microprocessor-controlled sphygmomanometer for recording blood pressure during exercise |
| Q40821191 | Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary prevention |
| Q92372673 | Feasibility and acceptability of opportunistic screening to detect atrial fibrillation in Aboriginal adults |
| Q51098348 | Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. |
| Q58645611 | Feasibility of screening for atrial fibrillation in primary care: Just a heartbeat away? |
| Q45924202 | Fog on the crystal ball? Missing atrial fibrillation in forecasting the future of stroke. |
| Q89783235 | High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice |
| Q91486801 | High-Throughput, Contact-Free Detection of Atrial Fibrillation From Video With Deep Learning |
| Q42832344 | Hypertriglyceridaemia is associated with early non-patency of coronary bypass grafts |
| Q58764949 | Identification of new-onset atrial fibrillation after cardiac surgery in Vietnam. A feasibility study of a novel screening strategy in a limited-resource setting: study protocol |
| Q30616300 | Identifying postoperative atrial fibrillation in cardiac surgical patients posthospital discharge, using iPhone ECG: a study protocol. |
| Q43073260 | Impact of medical consultation frequency on modifiable risk factors and medications at 12 months after acute coronary syndrome in the CHOICE randomised controlled trial |
| Q48412819 | Impact of sleep disordered breathing severity on hemodynamics, autonomic balance and cardiopulmonary functional status in chronic heart failure |
| Q54511916 | Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience. |
| Q58645733 | Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation |
| Q57820709 | Incidence of Atrial Fibrillation in Patients With Recent Ischemic Stroke Versus Matched Controls |
| Q47604909 | Incidence of postoperative atrial fibrillation recurrence in patients discharged in sinus rhythm after cardiac surgery: a systematic review and meta-analysis. |
| Q40607580 | Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013. |
| Q97635291 | Incremental yield of ECG screening repeated annually over 4 years in an adult Japanese population without prior atrial fibrillation: a retrospective cohort study |
| Q47883450 | Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference |
| Q58645642 | Is risk-benefit of warfarin for atrial fibrillation with heart failure determined by heart failure severity? |
| Q92639210 | Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study |
| Q58645660 | Isolated hypertrophy of the basal ventricular septum: Characteristics of patients with and without outflow tract obstruction |
| Q58645742 | Lack of widespread inflammation after contemporary PCI |
| Q39790265 | Late follow-up (41 to 102 months) of medically treated patients with coronary artery spasm and minor atherosclerotic coronary obstructions. |
| Q58645713 | Letter by Neubeck et al Regarding Article, “Impact of Cardiac Rehabilitation on Mortality and Cardiovascular Events After Percutaneous Coronary Intervention in the Community” |
| Q58645902 | Localization of coronary artery disease with exercise electrocardiography: correlation with thallium-201 myocardial perfusion scanning |
| Q33172939 | Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm. |
| Q46736878 | Low utilisation of cardiovascular risk reducing therapy in patients with acute coronary syndromes and non-obstructive coronary artery disease |
| Q51168513 | Lumen loss in the first year in saphenous vein grafts is predominantly a result of negative remodeling of the whole vessel rather than a result of changes in wall thickness. |
| Q90942951 | Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention? |
| Q39417976 | Management of atrial high-rate episodes detected by cardiac implanted electronic devices |
| Q45225513 | Medical graduates becoming rural doctors: rural background versus extended rural placement. |
| Q53345937 | Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience. |
| Q57465041 | National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018 |
| Q90752977 | National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018 |
| Q104572395 | Next frontier for stroke prevention in atrial fibrillation: ensuring anticoagulant persistence |
| Q58645718 | Nurse-Led Telephone Interventions for People with Cardiac Disease: The Importance of the Multi-Disciplinary Approach |
| Q90755811 | Opportunistic Electrocardiogram Screening for Atrial Fibrillation to Prevent Stroke |
| Q33451503 | Opportunistic screening to detect atrial fibrillation in Aboriginal adults in Australia |
| Q92055583 | Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group |
| Q34332051 | Participating in cardiac rehabilitation: a systematic review and meta-synthesis of qualitative data. |
| Q95497553 | Pharmacy-based screening for atrial fibrillation in high-risk Maori and Pacific populations |
| Q39841786 | Planning locally relevant Internet programs for secondary prevention of cardiovascular disease |
| Q46638741 | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. |
| Q58645880 | Prediction of multivessel coronary artery disease and prognosis early after acute myocardial infarction by exercise electrocardiography and thallium-201 myocardial perfusion scanning |
| Q46399266 | Prospective evaluation of the impact of diabetes and left ventricular hypertrophy on the relationship between ischemia and transient ischemic dilation of the left ventricle on single-day adenosine Tc-99m myocardial perfusion imaging. |
| Q90174755 | Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal |
| Q68032431 | Regional thallium uptake in irreversible defects |
| Q40975657 | Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans |
| Q40641454 | Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation. |
| Q45027423 | Risk of adverse outcome in patients admitted to the coronary care unit with suspected unstable angina pectoris |
| Q36060854 | Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke in an ambulant population aged >=65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocol |
| Q42397077 | Screening for Atrial Fibrillation Using a Smartphone: Is There an App for That? |
| Q30234524 | Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration |
| Q58645675 | Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke |
| Q33451647 | Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): A feasibility study. |
| Q47653704 | Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice |
| Q58645680 | Screening to identify unknown atrial fibrillation |
| Q91438856 | Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration |
| Q58645923 | Serial Thallium-201 Myocardial Perfusion Scanning in Acute Myocardial Infarction* |
| Q64120764 | Serum Amyloid A Stimulates Vascular and Renal Dysfunction in Apolipoprotein E-Deficient Mice Fed a Normal Chow Diet |
| Q58645765 | Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes |
| Q39969575 | Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes. |
| Q35723642 | Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells |
| Q50863299 | Serum amyloid A stimulates cultured endothelial cells to migrate and proliferate: inhibition by the multikinase inhibitor BIBF1120. |
| Q37189457 | Sleep disordered breathing in chronic heart failure. |
| Q47626928 | Smartphone electrographic monitoring for atrial fibrillation in acute ischemic stroke and transient ischemic attack |
| Q38580466 | Statin Therapy and Cognition in Older People: What is the Evidence? |
| Q56607937 | Stroke prevention in atrial fibrillation |
| Q50690124 | Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-making. |
| Q37798629 | Stroke risk and antithrombotic strategies in atrial fibrillation. |
| Q91153646 | Telehealth interventions for the secondary prevention of coronary heart disease: A systematic review and meta-analysis |
| Q37459112 | Testosterone treatment and risk of venous thromboembolism: population based case-control study |
| Q39197308 | The Word Heart Federation Roadmap for Nonvalvular Atrial Fibrillation |
| Q58645726 | The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein |
| Q58645779 | The late open artery hypothesis: the case and the artery remain closed |
| Q33443067 | The mobile revolution--using smartphone apps to prevent cardiovascular disease |
| Q50105606 | The role of atrial fibrillation in patients with an embolic stroke of unknown source (ESUS). |
| Q50998079 | Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study. |
| Q89824929 | Time to develop guidelines for screening and management of atrial fibrillation in Indigenous Australians |
| Q91763247 | Uptake of a primary care atrial fibrillation screening program (AF-SMART): a realist evaluation of implementation in metropolitan and rural general practice |
| Q58645895 | Verapamil in stable effort angina: Effects on left ventricular function evaluated with exercise radionuclide ventriculography |
| Q64941415 | eHealth Tools to Provide Structured Assistance for Atrial Fibrillation Screening, Management, and Guideline-Recommended Therapy in Metropolitan General Practice: The AF - SMART Study. |
| Q44825185 | iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke |
Search more.